Tag archives: Healthcare

Building the health systems of tomorrow: dealmaking and the future of the life sciences sector

By Troy Ungerman (Toronto) on April 23, 2019 Posted in M&A, Pharmaceuticals and life sciences

EY has recently published a year-in-review report for deal making in the global life sciences industry. The publication features some interesting statistics about deal activity in the past year, and makes predictions about which trends will carry forward into the 2019 and beyond. The total value of life sciences deals in 2018 was US $198 … Continue reading

Dissecting MedTech M&A deals

By Shreya Gupta (Toronto) on November 20, 2018 Posted in M&A, Pharmaceuticals and life sciences

As we previously reported, this year has seen a surge in healthcare-related M&A. Many of these transactions are in the medical technology industry, or MedTech. While the industry’s healthy profit margins and opportunities for growth have driven a flurry of activity, the potential for large rewards from MedTech acquisitions also comes with unique obstacles: Regulatory compliance: … Continue reading

A healthy dose of deal-making: M&A trends in the US and Canadian healthcare sector

By Troy Ungerman (Toronto) on May 3, 2018 Posted in M&A, Pharmaceuticals and life sciences

In the first quarter of 2018, M&A activity across the world hit a 17 year record high according to Mergermarket’s Q1 2018 Global M&A Report. This is an 18 percent increase in value compared to the first quarter of 2017. This increase was affected by the surge in deal-making seen at the end of 2017 … Continue reading

Private equity investments in healthcare: a look into the future

By Troy Ungerman (Toronto) on September 6, 2017 Posted in M&A, Pharmaceuticals and life sciences

Last year was a record-breaking year for private equity investments in the healthcare industry, with a total disclosed deal value reaching $36.4 billion by the end of 2016. Mid-year reviews of 2017 indicate a downward trend in the number of private equity investments but a significant increase in the value of investments compared to 2016. … Continue reading

M&A activity in the healthcare sector is on the rise

By Troy Ungerman (Toronto) on October 4, 2016 Posted in M&A, Pharmaceuticals and life sciences, Technology and innovation

M&A activity in the healthcare industry has been on an upwards trend since our last update. Good Foundations: Building Healthcare M&A and Real Estate, a report by Mergermarket on deal-making trends in the industry, found that about 90% of the respondents expect healthcare M&A to rise over the next year. The value of healthcare deals in … Continue reading

M&A prospects in the healthcare industry

By nrfdigitalteam on September 27, 2016 Posted in M&A, Pharmaceuticals and life sciences

RR Donnelley’s August 2016 VENUE Market Spotlight focused on the healthcare industry and the prospects for M&A activity in that space over the next 12 months. The report notes that there were 678 healthcare transactions in the first half of 2016 with an aggregate value of US$171.3 billion globally. These figures represent declines of 5% and … Continue reading

Reflections on American M&A performance in the first half of 2015

By Troy Ungerman (Toronto) on July 30, 2015 Posted in Corporate finance

As seen elsewhere in this blog, the volume of global mergers and acquisitions (M&A) in the first half of 2015 (H1 2015) reached near record-setting heights. According to a recent report from Deallogic, the total volume of M&A deals reached $2.28 trillion in H1 2015, second only to the $2.59 trillion recorded in the first … Continue reading

M&A: a leading growth strategy in 2015

By Troy Ungerman (Toronto) on December 16, 2014 Posted in Corporate finance, Pharmaceuticals and life sciences, Technology and innovation

The economic fundamentals that drive M&A are back at pre-crisis levels, states a new survey published by KPMG. The number of acquisitions that companies will undertake is expected to increase in 2015: 82% of respondents plan at least one acquisition and 10% anticipate 11 or more acquisitions next year. Indeed, the survey suggests M&A is … Continue reading

Increasing focus on M&A alternatives

By Troy Ungerman (Toronto) on October 17, 2012 Posted in Corporate finance, Finance, Financial institutions

With increasing cash reserves and a stagnant economy, firms are looking for alternatives to M&A for excess cash, including returning capital to shareholders by way of repurchase, dividend and debt reduction. According to the Thomson Reuters fourth annual Outlook for Investment Banking Services Survey, as valuations continue rising in the Americas, firms are becoming less interested in using … Continue reading